Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405729 · ClinicalTrials.gov registry record
Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 13
- Enrollment target
NCT01405729: Completed study, sponsored by University of Utah.
NCT01405729 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01405729 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this retrospective study was to determine the accuracy of femoral tunnel placement utilizing Redfern et al's radiographic method for anatomic femoral attachment during MPFL reconstruction in addition to the resultant outcome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-12 |
What the finished NCT01405729 record still lists
NCT01405729 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01405729 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01405729 about?
NCT01405729 is a clinical study titled "Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome". The purpose of this retrospective study was to determine the accuracy of femoral tunnel placement utilizing Redfern et al's radiographic method for anatomic femoral attachment during MPFL reconstruction in addition to the resultant outcome.
What is the current status of trial NCT01405729?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2010-05. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01405729?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia